Mixed results from regulator

TGA rebuffs Guild on advertising schedule change, while pain relieving agent moves to S2 A manufacturer's request to allow the advertising of preparations containing astrodrimer sodium has been rejected by the Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling (ACMS). Proposed amendments to the existing Appendix F and Appendix H entries for astodrimer that would